Thermo Fisher Scientific (Thermo Fisher Scientific) Risk Assessment

View and export this data going back to 1980. Start your Free Trial

What is Thermo Fisher Scientific Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Thermo Fisher Scientific is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Thermo Fisher Scientific's Risk Assessment

For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thermo Fisher Scientific's Risk Assessment Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Thermo Fisher Scientific's Risk Assessment falls into.

Thermo Fisher Scientific (NYSE:TMO) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Thermo Fisher Scientific Risk Assessment Related Terms

Thank you for viewing the detailed overview of Thermo Fisher Scientific's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Thermo Fisher Scientific (Thermo Fisher Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thermo Fisher Scientific Inc (NYSE:TMO) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

TMO:Peru TMO:Mexico TN8:Germany TN8:Germany TN8:Germany TMOS34:Brazil TMO:Argentina

Address

168 Third Avenue, Waltham, MA, USA, 02451

Website

https://www.thermofisher.com

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).

Executives

Marc N Casper	officer: Senior Vice President	C/O THERMO FISHER SCIENTIFIC, 168 THIRD AVENUE, WALTHAM MA 02451
Gianluca Pettiti	officer: Executive Vice President	C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Stephen Williamson	officer: Sr. VP and CFO	81 WYMAN STREET, WALTHAM MA 02451
Jennifer M Johnson	director	C/O FRANKLIN RESOURCES, INC., ONE FRANKLIN PARKWAY, SAN MATEO CA 94403-1906
Michael A Boxer	officer: Sr. VP and Gen. Counsel	168 THIRD AVENUE, WALTHAM MA 02451
Lisa P. Britt	officer: Sr. VP and Chief HR Officer	168 THIRD AVENUE, WALTHAM MA 02451
Jim P Manzi	director	81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454
Debora L Spar	director	C/O GOLDMAN, SACHS & CO., 200 WEST STREET, NEW YORK NY 10282
Michel Lagarde	officer: Senior Vice President	450 LEXINGTON AVE., 31ST FLOOR, NEW YORK NY 10017
Ruby R Chandy	director	630 DUNDEE ROAD, SUITE 400, NORTHBROOK IL 60062
Mark P Stevenson	officer: Executive Vice President	850 LINCOLN CENTRE DRIVE, FOSTER CITY CA 94404
Joseph R. Holmes	officer: VP & Chief Accounting Officer	168 THIRD AVENUE, WALTHAM MA 02451
R. Alexandra Keith	director	ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
Peter E Hornstra	officer: Chief Accounting Officer	81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454
Syed A. Jafry	officer: Sr. Vice President	345 E. MAIN STREET, WARSAW IN 46580